A new trading day began on Tuesday, with Unity Biotechnology Inc (NASDAQ: UBX) stock price up 16.00% from the previous day of trading, before settling in for the closing price of $0.70. UBX’s price has ranged from $0.66 to $3.10 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 30.13%. With a float of $15.68 million, this company’s outstanding shares have now reached $17.21 million.
Let’s determine the extent of company efficiency that accounts for 16 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Unity Biotechnology Inc (UBX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Unity Biotechnology Inc is 8.92%, while institutional ownership is 11.46%. The most recent insider transaction that took place on Apr 02 ’25, was worth 18,388. In this transaction CLO and Head of Ops of this company sold 17,852 shares at a rate of $1.03, taking the stock ownership to the 48,753 shares. Before that another transaction happened on Apr 02 ’25, when Company’s Officer proposed sale 17,852 for $1.03, making the entire transaction worth $18,305.
Unity Biotechnology Inc (UBX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 30.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.14% during the next five years compared to 39.36% growth over the previous five years of trading.
Unity Biotechnology Inc (NASDAQ: UBX) Trading Performance Indicators
Here are Unity Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.63, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -0.82 in one year’s time.
Technical Analysis of Unity Biotechnology Inc (UBX)
Looking closely at Unity Biotechnology Inc (NASDAQ: UBX), its last 5-days average volume was 1.63 million, which is a jump from its year-to-date volume of 0.29 million. As of the previous 9 days, the stock’s Stochastic %D was 27.41%. Additionally, its Average True Range was 0.09.
During the past 100 days, Unity Biotechnology Inc’s (UBX) raw stochastic average was set at 6.15%, which indicates a significant decrease from 31.91% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.28% in the past 14 days, which was lower than the 107.17% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8838, while its 200-day Moving Average is $1.3571.
